Skye Bioscience Inc (SKYE)
12.75
-0.16
(-1.24%)
USD |
NASDAQ |
May 07, 16:00
12.75
0.00 (0.00%)
After-Hours: 19:43
Skye Bioscience EPS Diluted (Quarterly): -0.3579 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.3579 |
| September 30, 2023 | -3.17 |
| June 30, 2023 | -0.8007 |
| March 31, 2023 | -2.50 |
| December 31, 2022 | -3.94 |
| September 30, 2022 | -1.58 |
| June 30, 2022 | -2.50 |
| March 31, 2022 | -2.50 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -1.103 |
| June 30, 2021 | -2.50 |
| March 31, 2021 | -2.50 |
| December 31, 2020 | -2.50 |
| September 30, 2020 | -2.50 |
| June 30, 2020 | -2.50 |
| March 31, 2020 | -2.50 |
| December 31, 2019 | -5.00 |
| September 30, 2019 | -10.00 |
| June 30, 2019 | 20.00 |
| March 31, 2019 | -27.50 |
| December 31, 2018 | -12.50 |
| September 30, 2018 | -5.00 |
| June 30, 2018 | -5.00 |
| March 31, 2018 | -22.50 |
| Date | Value |
|---|---|
| December 31, 2017 | 2.50 |
| September 30, 2017 | -5.00 |
| June 30, 2017 | -5.00 |
| March 31, 2017 | -22.50 |
| December 31, 2016 | -17.50 |
| September 30, 2016 | -12.50 |
| June 30, 2016 | 7.50 |
| March 31, 2016 | -20.00 |
| December 31, 2015 | -10.00 |
| September 30, 2015 | -17.50 |
| June 30, 2015 | -32.50 |
| March 31, 2015 | -15.00 |
| December 31, 2014 | -37.50 |
| September 30, 2014 | -20.00 |
| July 31, 2014 | 0.2269 |
| April 30, 2014 | -0.3951 |
| January 31, 2014 | 0.1058 |
| October 31, 2013 | -0.1511 |
| July 31, 2013 | -0.0208 |
| April 30, 2013 | 0.0605 |
| January 31, 2013 | 0.0057 |
| October 31, 2012 | 0.1361 |
| July 31, 2012 | 0.0016 |
| April 30, 2012 | -0.0111 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-10.00
Minimum
Sep 2019
20.00
Maximum
Jun 2019
-1.498
Average
-2.50
Median
Mar 2020
EPS Diluted (Quarterly) Benchmarks
| Cutera Inc | -2.27 |
| Medical Marijuana Inc | -- |
| OrthoPediatrics Corp | -0.29 |
| RAPT Therapeutics Inc | -0.81 |
| NovaBay Pharmaceuticals Inc | -0.8165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.420M |
| Total Expenses (Quarterly) | 4.086M |
| Enterprise Value | 365.41M |
| Earnings Yield | -53.56% |
| Normalized Earnings Yield | -3.681 |